1-4 of 4
Hélène Cavé, PhD
Close
Sort by
Journal Articles

Low CNS Relapse Incidence without Radiotherapy and Improvement of Outcome: Results of Subsequent EORTC-CLG 58881 and 58951 Trials in Pediatric T-Cell Acute Lymphoblastic Leukemia (ALL)

Barbara De Moerloose, Stefan Suciu, Alina Ferster, Françoise Mazingue, Nicolas Sirvent, Vitor Costa, Karima Yakouben, Patrick Lutz, Anne Uyttebroeck, Dominique Plantaz, Geneviève Plat, Frédéric Millot, Pierre Rohrlich, Maryline Poiree, Jutte Van der Werff Ten Bosch, Claire Hoyoux, Patrick Boutard, Hélène Cavé, PhD, Sandrine Girard, Francisco Bautista Sirvent, Yves Benoit, Yves Bertrand
Journal: Blood
Blood (2012) 120 (21): 133.
https://doi.org/10.1182/blood.V120.21.133.133
Published: 2012
Journal Articles

NRAS:BCL-2 Complex Localization Determines Anti-Apoptotic Features Associated with Progressive Disease in Myelodysplastic Syndromes (MDS)

Rose Ann Padua, PhD, Carole Le Pogam, MSc, Patricia Krief, PhD, Stephanie Beurlet, DMV, PhD, Bruno Cassinat, PharmD, PhD, Hélène Cavé, PhD, Olivier Kosmider, MD, PhD, Niclas Setterblad, PhD, Christophe Leboeuf, PhD, Laure Sarda-Mantel, MD, PhD, Florence Hervatin, PhD, Pascal Merlet, MD, Maria-Elena Noguera, MD, Anne Janin, MD, PhD, Marika Pla, PhD, Michaela Fontenay, MD, PhD, Lionel Ades, MD, PhD, Pierre Fenaux, MD, PhD, Christine Chomienne, MD, PhD, Nader Omidvar, PhD
Journal: Blood
Blood (2012) 120 (21): 3835.
https://doi.org/10.1182/blood.V120.21.3835.3835
Published: 2012
Journal Articles

Prolonged E. Coli Asparaginase Therapy Does Not Improve Significantly the Outcome for Children with Low and Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC-CLG Randomized Phase III Trial 58951

Veerle Mondelaers, Stefan Suciu, Barbara De Moerloose, Alina Ferster, MD, Françoise Mazingue, Geneviève Plat, Karima Yakouben, Anne Uyttebroeck, Patrick Lutz, Vitor Costa, Nicolas Sirvent, Pierre Rohrlich, Martine Munzer, Maryline Poiree, Patrick Boutard, Frédéric Millot, Dominique Plantaz, Philip Maes, Claire Hoyoux, Hélène Cavé, PhD, Yves Bertrand, Yves Benoit
Journal: Blood
Blood (2012) 120 (21): 134.
https://doi.org/10.1182/blood.V120.21.134.134
Published: 2012
Journal Articles

Minimal Residual Disease in High and Very High Risk ALL (HR/VHR-ALL) at the End of Induction (EOI) in FRALLE 2000 B and T Protocols.

Jean-Michel Cayuela, PhD, Kheira Beldjord, PhD, Nathalie Grardel, PhD, Hélène Cavé, PhD, Marie-Françoise Auclerc, MD, Anne Auvrignon, MD, Thierry Leblanc, MD, Yves Perel, MD, Françoise Mechinaud, MD, Claudine Schmitt, MD, Virginie Gandemer, MD, Pascale Schneider, MD, Claire Berger, MD, Xavier Rialland, MD, Catherine Paillard, MD, Odile Lejars, MD, Gerard Michel, MD, Guy Leverger, MD, Elizabeth A. Macintyre, MD, PhD, Andre Baruchel, MD
Journal: Blood
Blood (2007) 110 (11): 1427.
https://doi.org/10.1182/blood.V110.11.1427.1427
Published: 2007